
Daxor Investor Relations Material
Latest events

Q4 2024
Daxor
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Daxor Corp
Access all reports
Daxor Corp is a biotechnology company that specializes in the manufacture of medical equipment, specifically blood volume analyzers. The company's flagship product is the BVA-100 blood volume analyzer, which is a diagnostic tool used to measure human blood volume. This product is complemented by Volumex, a diagnostic radiopharmaceutical containing iodinated I 131 albumins. Daxor's technology finds application across a wide range of medical and surgical conditions, including congestive heart failure, critical care, kidney failure, hypertension, renal failure, and more, serving hospitals, clinics, and physicians. The company is headquartered in Oak Ridge, Tennessee, but also has a significant presence in New York, New York, where its business operations are primarily based. Its shares are listed on the Nasdaq.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
DXR
Country
🇺🇸 United States